Retractable Technologies, Inc (RVP) Stock Price

RVPStock

$0.58−41.21%52W

Market Cap$17.25M

P/E—

PEG Ratio—

Div yield—

Beta1.31

RVP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-24.44%

Price vs S&P 500 (4W)-17.52%

VGM Score45.57

Book Value / Share (Quarterly)$2.43

P/TBV (Annual)5.17x

Revenue Growth (3Y)-26.10%

Cash Flow / Share (Quarterly)$-0.17

Payout Ratio (TTM)3.60%

Price vs S&P 500 (YTD)-37.11%

Gross Margin (TTM)-1.45%

Net Profit Margin (TTM)-9.94%

EPS (TTM)$-0.11

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-0.11

Revenue Growth (5Y)-14.12%

EPS (Annual)$-0.42

Dividend / Share (Annual)$0.01

ROI (Annual)-16.63%

Gross Margin (Annual)4.83%

Net Profit Margin (5Y Avg)-9.95%

Cash / Share (Quarterly)$1.33

Revenue Growth QoQ (YoY)-31.07%

ROA (Last FY)-8.81%

Revenue Growth TTM (YoY)-11.16%

EBITD / Share (TTM)$-0.50

ROE (5Y Avg)4.75%

Operating Margin (TTM)-66.90%

Cash Flow / Share (Annual)$-0.25

P/B Ratio0.24x

P/B Ratio (Quarterly)0.30x

Net Income / Employee (Annual)$-64,400

EV / Revenue (TTM)0.46x

Net Interest Coverage (TTM)-1.44x

ROA (TTM)-2.37%

EV / EBITDA (TTM)4.15x

EPS Incl Extra (Annual)$-0.42

Current Ratio (Annual)6.57x

Quick Ratio (Quarterly)3.74x

3-Month Avg Trading Volume0.04M

52-Week Price Return-41.21%

Revenue / Employee (TTM)$173,900

Tangible BV / Share (Quarterly)$1.00

P/S Ratio (Annual)0.45x

Asset Turnover (Annual)0.27x

52-Week High$1.14

Operating Margin (5Y Avg)-20.45%

EPS Excl Extra (Annual)$-0.42

CapEx CAGR (5Y)-52.01%

Tangible BV CAGR (5Y)-5.61%

26-Week Price Return-14.54%

Quick Ratio (Annual)4.78x

13-Week Price Return-15.84%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)4.93x

Enterprise Value$15.58M

Revenue / Share Growth (5Y)-12.27%

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)11.10%

Revenue / Employee (Annual)$196,200

Inventory Turnover (Annual)2.00x

Pretax Margin (Annual)-32.08%

Cash / Share (Annual)$1.24

3-Month Return Std Dev25.18%

Gross Margin (5Y Avg)20.62%

Net Income / Employee (TTM)$-17,300

ROE (Last FY)-16.89%

Net Interest Coverage (Annual)-0.87x

EPS Basic Excl Extra (Annual)$-0.42

P/FCF (TTM)1.83x

Receivables Turnover (TTM)3.96x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.11

Receivables Turnover (Annual)4.88x

ROI (TTM)-4.52%

Dividend Growth Rate (5Y)3.13%

P/S Ratio (TTM)0.51x

Pretax Margin (5Y Avg)-3.58%

Revenue / Share (Annual)$1.28

Tangible BV / Share (Annual)$0.96

Price vs S&P 500 (52W)-56.75%

Year-to-Date Return-25.18%

5-Day Price Return-11.37%

EPS Normalized (Annual)$-0.42

ROA (5Y Avg)1.94%

Net Profit Margin (Annual)-32.84%

Month-to-Date Return-16.63%

Cash Flow / Share (TTM)$-0.13

EBITD / Share (Annual)$-0.38

Operating Margin (Annual)-50.37%

LT Debt / Equity (Annual)0.01x

ROI (5Y Avg)4.61%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.11

P/TBV (Quarterly)2.56x

P/B Ratio (Annual)0.31x

Dividend / Share (TTM)$0.01

Inventory Turnover (TTM)1.89x

Pretax Margin (TTM)-9.92%

Book Value / Share (Annual)$2.48

Price vs S&P 500 (13W)-18.52%

Dividend Yield (TTM)1.34%

Beta1.31x

P/FCF (Annual)9.01x

Revenue / Share (TTM)$1.13

ROE (TTM)-4.59%

52-Week Low$0.58

vGradeA

gGradeF

mGradeD

vgmGradeC

RVP Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2010	Jun 9, 2011	$0.01	-$0.04	-366.67%(-$0.06)
Q2 2010	Aug 16, 2010	—	-$0.13	—
Q1 2010	May 17, 2010	—	-$0.11	—

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
RVPRetractable Technologies, Inc	A	F	D	0.5x	-14.1%	-1.4%	-66.9%	$0.58
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Retractable Technologies, Inc

Retractable Technologies develops and manufactures safety-engineered syringes and injection systems for healthcare providers. Its branded products, including VanishPoint syringes and blood collection systems, emphasize needle safety features designed to reduce needlestick injuries. The company serves both U.S. and international markets with a focus on healthcare worker protection.